{"id":"q8438b2bdc06643fd7c7b","batch_id":"batch-000053","seq":252,"speaker":"tut***","date":"2025-10-29T21:40:58.562Z","text":"非常好 👍，我已经仔细读完你上传的《733动议》（白冉月 / Ryan Bai 的受害人动议）。\n下面是你问的重点——\n\n“我在 Cover Letter 里已经提到二巡的765，要不要再提一下733（也是白冉月的）？”\n\n答案是：\n✅ 可以提，而且非常合适。\n但要一句话点到为止，不要太长，放在你封面信（Cover Letter）里提到765的那段后面即可。\n\n⸻\n\n📄 一、为什么可以提733\n\n因为：\n    •    733 是 白冉月在 SDNY 提交的第一份动议（即她在原案法院的受害人动议），\n    •    765 是 她之后向二巡上诉法院提交的 Mandamus（强制令），\n    •    两者之间是直接的连续关系：\n“733 在南区被压制后 → 她向二巡提出765。”\n\n这对你的文件来说非常重要，因为你现在要提交的密封动议与她的路径是同一法律逻辑：\n\nSDNY 拒绝 docket → 二巡受理 Mandamus → 你在相同框架下行使受害者权利。\n\n⸻\n\n⚖️ 二、推荐的英文补充段落（加入在 Cover Letter 里）\n\n放在你已写的那一段里，稍作扩充即可：\n\n⸻\n\n✅ 修改后的完整段落建议：\n\nPlease also note that a related Mandamus proceeding has already been filed and docketed before the United States Court of Appeals for the Second Circuit — In re Ranyue Bai, No. 25-2726 (2d Cir. 2025) — which raises substantially identical issues concerning the SDNY’s refusal to docket third-party victim motions under 21 U.S.C. §853(n) and the Crime Victims’ Rights Act (18 U.S.C. §3771).\n\nThis appellate proceeding arises directly from Ms. Bai’s prior filing in the district court, Dkt. 733, which raised comparable CVRA and procedural fraud concerns. My present submission is made in good faith and in parallel, consistent with the rights preserved under the CVRA and the appellate court’s ongoing oversight.\n\n⸻\n\n🇨🇳 中文对应说明（仅供你参考，不需打印）\n\n请法庭注意，美国第二巡回上诉法院已正式立案受理案件 In re Ranyue Bai, No. 25-2726（2025年），\n该案源自纽约南区刑事案卷中的第733号动议，提出了与本案相同的程序性与CVRA受害者权利问题。\n本次提交与该上诉案件保持平行关系，在相同法律框架下依法提出。\n\n⸻\n\n📌 三、效果说明\n\n这样写的好处是：\n    •    ✅ 你同时引用了白冉月的733和765，形成“前后呼应”的司法链条；\n    •    ✅ 不破坏你的信件结构，法官或书记员一眼就能理解关系；\n    •    ✅ 表明你不是孤立的个人请求，而是属于“已被二巡受理监督范围内的同类受害者”。\n\n⸻\n\n🟩 结论\n\n✔️ 加上 733 是明智的，会让你文件更有法律延续性与说服力。\n✔️ 就用我上面那两段英文（第二段加一句提733），放在你原 Cover Letter 里提765那段之后即可。\n\n⸻\n\n是否希望我帮你把你现在的 Cover Letter 完整改成最终版（含 733 + 765 引用），格式好到可以直接打印寄出？","edited":false,"reply_to":null,"reply_status":"none","has_attachment":false,"url":"https://mubeitech.com/discussions/messages/q8438b2bdc06643fd7c7b","reply_url":null,"reply_label":"","batch_url":"https://mubeitech.com/discussions/batches/batch-000053","batch_canonical_url":"https://mubeitech.com/discussions/batches/batch-000053","notice":"围绕郭文贵案的社区讨论与观点交锋。发言仅代表讨论者观点，不等同于法院认定。","content_type":"discussion_message","canonical_url":"https://mubeitech.com/discussions/messages/q8438b2bdc06643fd7c7b","markdown_url":"https://mubeitech.com/discussions/messages/q8438b2bdc06643fd7c7b/markdown","json_url":"https://mubeitech.com/api/discussion-messages/q8438b2bdc06643fd7c7b","surrounding_messages":[{"id":"q121a9aee92c29c010032","speaker":"ntp***","date":"2025-10-29T19:59:07.746Z","url":"https://mubeitech.com/discussions/messages/q121a9aee92c29c010032"},{"id":"q038af5f1038cc7a6438b","speaker":"hon***","date":"2025-10-29T19:59:21.084Z","url":"https://mubeitech.com/discussions/messages/q038af5f1038cc7a6438b"},{"id":"q88eba3960e0e50884d7d","speaker":"him***","date":"2025-10-29T21:38:58.375Z","url":"https://mubeitech.com/discussions/messages/q88eba3960e0e50884d7d"},{"id":"q1f514cb3641aa6f649fe","speaker":"him***","date":"2025-10-29T21:41:01.582Z","url":"https://mubeitech.com/discussions/messages/q1f514cb3641aa6f649fe"},{"id":"q4368231bd0fae94074ea","speaker":"rui***","date":"2025-10-29T21:41:29.577Z","url":"https://mubeitech.com/discussions/messages/q4368231bd0fae94074ea"},{"id":"q1298d596dfaa4011f577","speaker":"sar***","date":"2025-10-29T21:41:32.988Z","url":"https://mubeitech.com/discussions/messages/q1298d596dfaa4011f577"}],"parent_message":null}